VERNIERI, FABRIZIO
 Distribuzione geografica
Continente #
AS - Asia 10.398
NA - Nord America 4.606
EU - Europa 1.739
SA - Sud America 809
AF - Africa 79
Continente sconosciuto - Info sul continente non disponibili 51
OC - Oceania 19
AN - Antartide 1
Totale 17.702
Nazione #
SG - Singapore 7.574
US - Stati Uniti d'America 4.449
CN - Cina 1.204
IT - Italia 835
HK - Hong Kong 817
BR - Brasile 590
VN - Vietnam 326
GB - Regno Unito 254
FR - Francia 212
BD - Bangladesh 141
DE - Germania 134
AR - Argentina 83
IN - India 78
CA - Canada 67
ID - Indonesia 53
FI - Finlandia 43
NL - Olanda 37
EC - Ecuador 36
EE - Estonia 36
CO - Colombia 35
MX - Messico 32
TR - Turchia 27
UA - Ucraina 26
IQ - Iraq 24
RU - Federazione Russa 24
JP - Giappone 22
ES - Italia 21
ZA - Sudafrica 20
AU - Australia 18
PK - Pakistan 18
SA - Arabia Saudita 17
AT - Austria 16
VE - Venezuela 16
JM - Giamaica 15
PL - Polonia 15
CL - Cile 14
MA - Marocco 13
MY - Malesia 13
PH - Filippine 13
PY - Paraguay 13
MD - Moldavia 12
SE - Svezia 12
PE - Perù 11
CZ - Repubblica Ceca 10
UZ - Uzbekistan 10
TH - Thailandia 9
KZ - Kazakistan 8
LT - Lituania 8
DO - Repubblica Dominicana 7
DZ - Algeria 7
GT - Guatemala 7
TN - Tunisia 7
EG - Egitto 6
HN - Honduras 6
HR - Croazia 6
PA - Panama 6
CR - Costa Rica 5
PT - Portogallo 5
UY - Uruguay 5
AL - Albania 4
BO - Bolivia 4
GE - Georgia 4
HU - Ungheria 4
KE - Kenya 4
KR - Corea 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
GR - Grecia 3
KG - Kirghizistan 3
KW - Kuwait 3
NP - Nepal 3
OM - Oman 3
SN - Senegal 3
SV - El Salvador 3
BG - Bulgaria 2
BW - Botswana 2
CH - Svizzera 2
CY - Cipro 2
ET - Etiopia 2
JO - Giordania 2
LB - Libano 2
LV - Lettonia 2
MN - Mongolia 2
MT - Malta 2
MW - Malawi 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RO - Romania 2
RS - Serbia 2
SC - Seychelles 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AM - Armenia 1
AQ - Antartide 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
Totale 17.624
Città #
San Jose 1.221
Ashburn 876
Hong Kong 809
Singapore 688
Rome 512
Hefei 420
Council Bluffs 276
Beijing 258
Columbus 224
Boardman 216
London 193
Lauterbourg 181
Dallas 176
Shanghai 140
Ho Chi Minh City 121
New York 84
Santa Clara 78
Hanoi 73
Los Angeles 69
Phoenix 63
San Francisco 63
São Paulo 57
Munich 39
Milan 32
Pune 29
Seattle 29
Helsinki 21
Sona 21
Toronto 21
Turku 20
Washington 20
Las Vegas 19
Amsterdam 18
Chicago 18
Rio de Janeiro 17
Naples 16
Frankfurt am Main 15
Nuremberg 15
Tokyo 15
Atlanta 14
Florence 14
Quito 14
Warsaw 14
Baghdad 13
Brasília 13
Brooklyn 13
Haiphong 13
Montreal 13
Boston 12
Guayaquil 12
Buffalo 11
Mexico City 11
Chennai 10
West Jordan 10
Kingston 9
Manchester 9
Redmond 9
Tashkent 9
Bogotá 8
Bologna 8
Brno 8
Charlotte 8
Melbourne 8
Orem 8
Philadelphia 8
Porto Alegre 8
Stockholm 8
Curitiba 7
Da Nang 7
Genoa 7
Guangzhou 7
Jakarta 7
Joinville 7
Osasco 7
Riyadh 7
Staten Island 7
Thái Bình 7
Turin 7
Buenos Aires 6
Changsha 6
Dhaka 6
Guatemala City 6
Ha Long 6
Houston 6
Johannesburg 6
Lima 6
Manaus 6
Medellín 6
Newark 6
Paris 6
Salvador 6
San Antonio 6
Santa Fe 6
Vienna 6
Ankara 5
Bangkok 5
Cali 5
Can Tho 5
Canberra 5
Denver 5
Totale 7.661
Nome #
1-Hz repetitive transcranial magnetic stimulation increases cerebral vasomotor reactivity: a possible autonomic nervous system modulation 398
Stroke territory and atherosclerosis in ischemic stroke patients with a history of migraine with aura 268
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy 262
Hyperhomocysteinemia, intima-media thickness and C677T MTHFR gene polymorphism: A correlation study in patients with cognitive impairment 261
Psychopathological variables in chronic migraine patients with different therapeutic approach: psychological profile differences and impact on therapeutic efficacy in real life 242
A contralesional EEG power increase mediated by interhemispheric disconnection provides negative prognosis in acute stroke 242
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 235
Task-switching abilities in episodic and chronic migraine 234
OnabotulinumtoxinA in elderly patients with chronic migraine: insights from a real-life European multicenter study 230
Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment 230
Acute Carotid Dissection in an Adult Caused by Pertussis 227
Correction to: Task-switching abilities in episodic and chronic migraine (Neurological Sciences, (2022), 10.1007/s10072-021-05837-4) 221
Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real-life perspective from the Italian chROnic migraiNe (IRON) project 218
Eptinezumab for the Prevention of Migraine: Clinical Utility, Patient Preferences and Selection - A Narrative Review 210
Improving distress perception and mutuality in migraine caregivers after 6 months of galcanezumab treatment 208
Cerebral Hemodynamics, Right-to-Left Shunt and White Matter Hyperintensities in Patients with Migraine with Aura, Young Stroke Patients and Controls 206
Cerebral distribution of white matter lesions in migraine with aura patients 204
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study 203
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study 201
CAROTID WALL THICKNESS AND STROKE RISK IN PATIENTS WITH ASYMPTOMATIC INTERNAL CAROTID STENOSIS 200
Cerebral vasomotor reactivity in the acute phase and after 6 months in non-disabling stroke/TIA: A prospective cohort study 192
Association between the c. 2495 A>G ATP7B Polymorphism and Sporadic Alzheimer's Disease 191
Right-to-Left Shunt and the Clinical Features of Migraine with Aura: Earlier but Not More 187
Acute hyperglycemia reduces cerebrovascular reactivity: the role of glycemic variability 179
Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study 161
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study 156
Cerebral Hemodynamics, Patent foramen ovale and White Matter Hyperintensities in patients Migraine with aura, young stroke patients and controls 154
Frequency and clinical implications of hypercoagulability states in a cohort of patients with migraine with aura 150
Neurophysiological Bases of Tremors and Accelerometric Parameters Analysis 135
Epicentral disruption of structural connectivity in Alzheimer's disease 133
Effects of prophylactic drug therapies and anti-calcitonin peptide-related monoclonal antibodies on subjective sleep quality: An Italian multicenter study 132
Gepants - a long way to cure: a narrative review 131
Cortical brain connectivity evaluated by graph theory in dementia: a correlation study between functional and structural data. 131
Unilateral cortical hyperexcitability in congenital hydrocephalus: A TMS study 131
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 129
Carotid Artery Plaque Progression: Proposal of a New Predictive Score and Role of Carotid Intima-Media Thickness 129
Blood pressure monitoring in elderly migraineurs starting an anti-CGRP monoclonal antibody: a real-world prospective study 128
Movement disorders and brain iron overload in a new subtype of aceruloplasminemia 127
An improved I-FAST system for the diagnosis of Alzheimer's disease from unprocessed electroencephalograms by using robust invariant features 127
Acute medications' intake for migraine: a one-year report in patients undergoing first evaluation at a third level Italian headache center 126
Relationship among diffusion tensor imaging, EEG activity, and cognitive status in mild cognitive impairment and Alzheimer's disease patients 126
Blood pressure levels and risk of stroke in elderly patients 124
Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients 122
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study 122
Antioxidant status and APOE genotype as susceptibility factors for neurodegeneration in Alzheimer's disease and vascular dementia 121
Basilar and middle cerebral artery reactivity in patients with migraine 119
Calcitonin Gene-Related Peptide Systemic Effects: Embracing the Complexity of Its Biological Roles-A Narrative Review 118
Association of reversed Robin Hood syndrome with risk of stroke recurrence 118
Resting state cortical electroencephalographic rhythms are related to gray matter volume in subjects with mild cognitive impairment and Alzheimer's disease 117
Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study 116
An unusual cause of dementia: essential diagnostic elements of corticobasal degeneration-a case report and review of the literature 116
Are autonomic signals influencing cortico-spinal motor excitability? A study with transcranial magnetic stimulation 115
Motor cortex excitability in Alzheimer's disease: a transcranial magnetic stimulation follow-up study 115
Cerebrovascular reactivity predicts stroke in high-grade carotid artery disease 115
Effect of Atogepant on Sleep Quality and Sleep-Related Adverse Events in Adult Patients with Migraine: A Prospective Observational 12-Week Study 115
Regional MRI Diffusion, White-Matter Hyperintensities, and Cognitive Function in Alzheimer's Disease and Vascular Dementia 114
Altered Cerebral Vasoregulation Predicts the Outcome of Patients with Partial Anterior Circulation Stroke 114
Association between sex, systemic iron variation and probability of Parkinson's disease 113
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study 111
Association of K832R and R952K SNPs of Wilson's Disease Gene with Alzheimer's Disease 110
Carotid atherosclerosis and cognitive decline in patients with Alzheimer's disease 109
Cerebrovascular assessment for the risk prediction of Alzheimer's disease 109
Relationship among Fractional Anisotropy (FA) values, EEG activity and cognitive status in Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) patients 108
Diffusion-weighted lesions after carotid artery stenting are associated with cognitive impairment 107
Ceruloplasmin/Transferrin system is related to clinical status in acute stroke 105
Patients with migraine with aura have increased flow mediated dilation 104
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study 99
The role of endothelial dysfunction in the pathophysiology and cerebrovascular effects of migraine: A narrative review 98
Alpha and beta EEG power reflects L-dopa acute administration in parkinsonian patients 96
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study) 90
ATP7B variants as modulators of copper dyshomeostasis in Alzheimer's disease 89
Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease 80
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience 80
Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) 79
The genetic landscape of patent foramen ovale: A systematic review 72
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients 71
Inter-hemispheric coupling changes associate with motor improvements after robotic stroke rehabilitation 71
Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY) 69
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study 68
The evolving concept of multimorbidity and migraine 68
Robot-aided therapy for upper limbs in patient with chronic stroke-related lesions. Brief report of a clinical experience 67
Reducing the Impact of Headache and Allodynia Score in Chronic Migraine: An Exploratory Analysis from the Real-World Effectiveness of Anti-CGRP Monoclonal Antibodies Compared to Onabotulinum Toxin A (RAMO) Study 65
Vascular predictors of cognitive decline in patients with mild cognitive impairment 64
Complex visual hallucinations after occipital extrastriate ischemic stroke 64
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study 64
Erenumab does not alter cerebral hemodynamics and endothelial function in migraine without aura 63
Shorter visual aura characterizes young and middle-aged stroke patients with migraine with aura 63
Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study 63
fMRI-vs-MEG evaluation of post-stroke interhemispheric asymmetries in primary sensorimotor hand areas 62
Stability of clinical condition in mild cognitive impairment is related to cortical sources of alpha rhythms: an electroencephalographic study 62
Does cerebrovascular disease affect the coupling between neuronal activity and local haemodynamics? 60
Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis 60
Gadolinium Enhancement in a Case of Uncomplicated Posterior Reversible Encephalopathy Syndrome 59
Cortical ischemic lesion burden measured by DIR is related to carotid artery disease severity 59
Cortical neuromodulation modifies cerebral vasomotor reactivity 59
The Healthy Eating Plate Advice for Migraine Prevention: An Interventional Study 59
Markers for the risk of progression from mild cognitive impairment to Alzheimer's disease 57
Patent foramen ovale and migraine with aura in a retrospective analysis: age matters 57
Markers of lacunar stroke in patients with moderate internal carotid artery stenosis 57
Correlation of cerebral hemodynamic changes during mental activity and recovery after stroke 57
Totale 12.963
Categoria #
all - tutte 107.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.702


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022246 0 0 0 0 0 0 0 1 18 4 0 223
2022/202388 7 3 4 5 8 4 4 11 8 4 25 5
2023/2024619 24 74 26 53 76 267 6 48 6 12 12 15
2024/20258.484 72 65 234 17 24 117 137 64 566 702 2.993 3.493
2025/20266.656 644 326 468 885 248 371 1.725 426 534 470 324 235
2026/20271.598 103 688 508 299 0 0 0 0 0 0 0 0
Totale 17.702